On 24th July, it was announced that Steve Anderson, MD of PHOENIX UK, has been appointed to the Executive Board of the PHOENIX group in Europe with effect from 1 September. He will continue as MD in the UK along with his new Executive Board responsibilities.

Steve comments: “I am delighted to join the Board and help drive our growth strategy across Europe.

“Over the last two years, PHOENIX in the UK has implemented successfully a strategy to grow profitably; our performance has outstripped the market and main competitors in volume and value; we have won more contracts with manufacturers; we have introduced sector-leading innovations such as MediPAC and NuPAC; we have reorganised our management structures to become a more agile and responsive business; we have begun a journey to transform the performance and profitability of our retail network; we have delivered outstanding operational efficiencies in our distribution business.

“We have ambitious plans for the years ahead to build on that success. PHOENIX groups’ European subsidiaries have the same growth ambitions and therefore the UK’s experience and learnings will be useful.”

Healthcare Professional ONLY
This website is intended for Healthcare professionals only

Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors